<?xml version="1.0" encoding="UTF-8"?>
<ref id="B86-biomedicines-08-00109">
 <label>86.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Arabi</surname>
    <given-names>Y.M.</given-names>
   </name>
   <name>
    <surname>Alothman</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Balkhy</surname>
    <given-names>H.H.</given-names>
   </name>
   <name>
    <surname>Al-Dawood</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Al Johani</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Al Harbi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kojan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Al Jeraisy</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Deeb</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Assiri</surname>
    <given-names>A.M.</given-names>
   </name>
  </person-group>
  <article-title>Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-Î²1b (MIRACLE) trial: Study protocol for a randomized controlled trial</article-title>
  <source>Trials</source>
  <year>2018</year>
  <volume>19</volume>
  <fpage>81</fpage>
  <pub-id pub-id-type="doi">10.1186/s13063-017-2427-0</pub-id>
  <pub-id pub-id-type="pmid">29382391</pub-id>
 </element-citation>
</ref>
